6652 Share Price Performance
NT$1.96
-4.07 (-67.50%)
Price NT$1.96
Share Pricen/a
Eusol Biotech Co.,Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
6652 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Eusol Biotech Co.,Ltd. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -0.30
- 32.16%
- -1,945.88%
- 0%
About 6652
- Founded
- 1994
- Employees
- n/a
- CEO
- WebsiteView website
Eusol Biotech Co.,Ltd. focuses on research and development of new drugs for the treatment of nerve injuries in Hong Kong and Taiwan. The company’s pipeline includes ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) for spinal cord injury that is in phase 1, 2, and 3 clinical trials, and SM-1, a 3-in-1 combination sleeping aid. It also offers small molecule drugs including EPS221, a selective serotonin reuptake inhibitor; EPS222, a calcium channel blocker for cardiovascular disease; EPS251, a drug for rheumatology/anti-inflammation; and EA2501, a drug for anticoagulation. The company was founded in 1994 and is headquartered in Taipei, Taiwan.
